Good Morning,
On behalf of ESSO, we would like to invite you to take part in a survey exploring practices in the management of neuroendocrine tumors, including insights into the use of Peptide Receptor Radionuclide Therapy (PRRT).
The survey is open to all healthcare professionals involved in the care of patients with neuroendocrine tumors—whether in training, residency, or fully qualified—and regardless of their level of experience or case volume. The survey is anonymized and can be accessed via the provided link www.tinyurl.com/esso2025 or by scanning the QR code in the attached flyer. It takes about 8 mins to complete, and we will be grateful for filling out all sections. We would greatly appreciate sharing this survey with your members, for example through a direct email, newsletter, or your society’s website. Gaining a better understanding of clinicians’ experiences and the challenges they face will help us enhance patient care across Europe.
Thank you very much for your support and for your continued collaboration with ESSO as one of our valued affiliated national societies.
Best Regards